Welcome to Valens GroWorks Corp.

Okanagan Valley, British Columbia

About Us

Positioned for Rapid Growth

  “From Plants to Premium Products”  

Rapidly emerging biotechnology company focused on cannabis cultivation and research; based in the Okanagan Valley of B.C.  

Canadian Market - Int'l Leadership

Positioned to capitalize on Canada’s international lead in regulation, research, development and production, to become a global, vertically integrated medical cannabis company.

Assembling “Best-In-Class” fully licensed cannabis focused companies that are horizontally integrated “From Plants to Premium Products”

Mission Statement

  To be the most profitable, fully-integrated Plants to Premium Products (“P2P”) cannabis-focused company through the creation of a “Best Practices, R&D-backed, end-to-end Global Bioscience Platform”.

Focused on quality organic product demanding premium pricing with exceptional profit margins

Our Operations

Valens Agritech Ltd., Kelowna, BC

www.valensagritech.com

17,000 sf state-of-the-art research Cannabis Cultivation Facility

  • Health Canada Level 7 security (Dealer's Licence rec'd May 18 2017)
  • $6.125M of controlled substance capacity = 625 kg of Cannabis)
  • Unique medical strain genetics (Cannabinoid/Terpene optimization)

Customized Derivative Production

  • Quality Oil Extract process: Solvent-free, Organic, 100% Cannabis
  • Custom extraction - quality oil for NHP: Essential Oils & Terpenes
  • GMP & ISO 9001 derivative production – NHP’s, Edibles
  • Custom packaging & authentication (RFID tags, Chemical Fingerprint)

Contract R&D Operations

  • 3rd Party Clinical trials management, Custom formulation & production
  • Derivative formulations, Extraction technology, etc.
  • Pharmacology absorption optimization
  • Add-on LP application
  • Licensed Producer infrastructure in place for premium production

Supra THC Services Inc., Kelowna, BC

www.suprathc.com

Leading Edge Analytical Services & Research

Analytical Services:

  • Sector Leading Analytical Instrumentation Infrastructure
  • Centre of Excellence in “Plant Based Medicines”
  • ISO 17025 accreditation (pending)

Consulting Services:

  • Lab Set-Up, QA/QC
  • Government Funding: NSERC, MITACS, IRAP, SR&ED
  • Chemometrics and Big Data Statistical Experience
  • Expert Support Provider: BIKA LIMS Systems

Research and Development:

  • Collaboration with: NRC, UBC, TRU, and UofA
  • Custom Product Development
  • Clinical Studies, Molecular Epidemiology
  • Biomarker Tracking

Supra is licensed by Health Canada to conduct research, provide chemical analysis and produce extracts and derivatives of cannabis materials in addition to offering analytical services to the wider natural health product sector. Our corporate mandate is to provide scientific leadership and to support the production of the highest quality herbal medicinal products on the market.

Kelowna Operations LP-licence Expansion (PROPOSED)

Facilities Build Out, Licensing & Production

On May 26, 2017 Health Canada introduced several improvements to its medical cannabis program, expected to have direct application to the Company’s expansion plans.

Potential near-term issuance of an LP to the Company, and expedited acquisition of an LS concurrent to our DL cultivation activities.

Assumptions, based on management estimates and experience:

  • $6.5M build-out cost (approx)
  • 38,000 sf two-level building addition
  • Lower-level indoor production
  • Upper-level greenhouse production
  • Projected gross retail revenue ~$40,950,000\yr from expansion

Also, grow-room expansion and additions to extraction capability is commencing to accommodate initial harvests to meet Dealers Licence-related commercial purchase orders. This will include Food Grade/ISO Certification, vault renovation, ISO 9001 extraction & derivative production.  

Tucson, Arizona

MKV Ventures 1, LLC (“MKV”), a wholly-owned subsidiary of MKHS, LLC, has engaged VGW to help manage and fund expansion on its 9.5 acre operating site:

  • MKV completing VGW-funded 28,000-sf Farmtek Greenhouse Expansion
  • VGW funded $1,628,266 (US$1,212,500) secured by a promissory note (the “Loan”)
  • The Loan accrues interest effective May 15, 2016 @ 15% p.a.
  • Loan repayment + $30,000 in fees starts with first crop, P+I, 5-year term
  • Unconditionally guaranteed by established licenced operator MKHS
  • VGW has 5-year, renewable, Professional Services Agreement (the “PSA”) with MKV
  • VGW collects US$60,000/mo under the PSA after buildout for management services
  • VGW bills additional consulting services, to be invoiced monthly
  • VGW is reimbursed for approved out-of-pocket expenses and sub-contracted services
  • Buildout is currently under construction; Cash flow expected by late 2017


Download

Download our latest Corporate Presentation:

Subscribe

We are a publicly traded Canadian company listed on the Canadian Securities Exchange (VGW-C).

We just completed (Nov 2016) an RTO and changed our name from Genovation Capital Corp.

Our old website with historical filings remains accessible at www.genovationcapital.ca pending the rollout of our permanent website.

Contact Us

Drop us a line!

Better yet, see us in person!

We love to meet with our shareholders, potential investors and industry participants, so feel free to arrange a visit during normal business hours at our Okanagan Valley facility.

Our predeccesor website with our Financial Statements, as well as all News Releases, is found here:

www.genovationcapital.ca